author-photo

Anja Mueller

Martin Luther University of Halle-Wittenberg

19

Papers

273

Citations

Citation Trend

Filter By

Papers (19) Sort By

JournalConferenceOthers

Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment with Everolimus in Second-Line Metastatic Clear Cell Renal Cell Carcinoma (MARC-2 Study).

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma.

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (1)
Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma.

2020 Journal of Clinical Medicine
Show All
- Source
- Cite
- Save
Citations (10)
Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients

2020 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (7)
Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744.

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (4)
Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC.

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (2)
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy

2019 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (45)
Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display

2019 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (14)
Correlation of the tumor mutational burden with the composition of the immune cell subpopulations in peripheral blood of triple-negative breast cancer patients undergoing neoadjuvant therapy with durvalumab: Results from the prospectively randomized GeparNuevo trial.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
PD57-06 ALTERED IMMUNE CELL REPERTOIRE AND ACTIVITY AFTER CHECKPOINT BLOCKADE IMMUNOTHERAPY WITH NIVOLUMAB IN RENAL CELL CARCINOMA

2018 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号